2. Academic Validation
  3. Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus

Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus

  • Virol Sin. 2022 Feb;37(1):145-148. doi: 10.1016/j.virs.2022.01.014.
Jingjing Yang 1,  Yunzheng Yan 2,  Qingsong Dai 2,  Jiye Yin 2,  Lei Zhao 2,  Yuexiang Li 2,  Wei Li 2,  Wu Zhong 2,  Ruiyuan Cao 3,  Song Li 4
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • 2 National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China.
  • 3 National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. Electronic address: 21cc@163.com.
  • 4 School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; National Engineering Research Centre for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. Electronic address: lis.lisong@gmail.com.
PMID: 35234618 DOI: 10.1016/j.virs.2022.01.014
Abstract

  1. •

    Tilorone dihydrochloride possesses robust anti-SFTSV activity in vitro and in vivo.

  2. •

    Intraperitoneal administration of tilorone leads to protection against intracranial lethal challenge of SFTSV.

  3. •

    The anti-SFTSV mechanism of tilorone is through stimulation of host innate immunity.

  4. •

    Pre-treatment with tilorone can prevent mice from lethal SFTSV challenge.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z